Literature DB >> 19733173

Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function.

Boris B Gorzalka1, Matthew N Hill, Sabrina C H Chang.   

Abstract

The putative role of the endocannabinoid system and the effects of cannabis use in male and female sexual functioning are summarized. The influence of cannabis intake on sexual behavior and arousability appear to be dose-dependent in both men and women, although women are far more consistent in reporting facilitatory effects. Furthermore, evidence from nonhuman species indicate somewhat more beneficial than debilitating effects of cannabinoids on female sexual proceptivity and receptivity while suggesting predominantly detrimental effects on male sexual motivation and erectile functioning. Data from human and nonhuman species converge on the ephemeral nature of THC-induced testosterone decline. However, it is clear that cannabinoid-induced inhibition of male sexual behavior is independent of concurrent declines in testosterone levels. Investigations also reveal a suppression of gonadotropin release by cannabinoids across various species. Historical milestones and promising future directions in the area of cannabinoid and sexuality research are also outlined in this review. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733173     DOI: 10.1016/j.yhbeh.2009.08.009

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  25 in total

1.  Marijuana use and testicular germ cell tumors.

Authors:  Britton Trabert; Alice J Sigurdson; Anne M Sweeney; Sara S Strom; Katherine A McGlynn
Journal:  Cancer       Date:  2010-10-05       Impact factor: 6.860

2.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Authors:  Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

Review 3.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

Review 4.  Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility.

Authors:  Stefan S du Plessis; Ashok Agarwal; Arun Syriac
Journal:  J Assist Reprod Genet       Date:  2015-08-16       Impact factor: 3.412

Review 5.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 6.  How important are sex differences in cannabinoid action?

Authors:  Liana Fattore; Walter Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

7.  Estrogenic regulation of limbic cannabinoid receptor binding.

Authors:  Caitlin J N Riebe; Matthew N Hill; Tiffany T Y Lee; Cecilia J Hillard; Boris B Gorzalka
Journal:  Psychoneuroendocrinology       Date:  2010-03-06       Impact factor: 4.905

8.  Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice.

Authors:  Carmelo Quarta; Daniela Cota
Journal:  Int J Obes (Lond)       Date:  2020-04-21       Impact factor: 5.095

9.  Circulating endocannabinoid concentrations and sexual arousal in women.

Authors:  Carolin Klein; Matthew N Hill; Sabrina C H Chang; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Sex Med       Date:  2012-03-29       Impact factor: 3.802

Review 10.  Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids.

Authors:  Matthew N Hill; Bruce S McEwen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-10       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.